1
/
of
0
FDA Drug/Biologics Approval BLA 020986 S-040, INSULIN ASPART RECOMBINANT
FDA Drug/Biologics Approval BLA 020986 S-040, INSULIN ASPART RECOMBINANT
Regular price
$49.00 USD
Regular price
Sale price
$49.00 USD
Unit price
/
per
BLA 020986 S-040
Company: NOVO NORDISK INC
Drug Name: NOVOLOG PENFILL
Active Ingredients: INSULIN ASPART RECOMBINANT
Strength: 300 UNITS/3ML (100 UNITS/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 06/07/2000
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: NOVO NORDISK INC
Drug Name: NOVOLOG PENFILL
Active Ingredients: INSULIN ASPART RECOMBINANT
Strength: 300 UNITS/3ML (100 UNITS/ML)
Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
Action Date: 06/07/2000
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details